Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents
Related Experiment Videos
A V Schally1, T W Redding, J I Paz-Bouza
1Endocrine, Polypeptide and Cancer Institute, VA Medical Center, New Orleans, LA.
Progress in Clinical and Biological Research
|January 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.
Cellular and molecular life sciences : CMLS·2004
Hypothalamic hormones and cancer.
Frontiers in neuroendocrinology·2001
Peptide analogs in the therapy of prostate cancer.
The Prostate·2000
Efficacy and safety of luteinizing hormone-releasing hormone antagonist cetrorelix in the treatment of symptomatic benign prostatic hyperplasia.
The Journal of clinical endocrinology and metabolism·1998
Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.
Human reproduction (Oxford, England)·1997
Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview.
Human reproduction (Oxford, England)·1995
DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.
Progress in clinical and biological research·2018
Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.
Progress in clinical and biological research·1998
The molecular basis for therapeutic concepts utilizing CD14.
Progress in clinical and biological research·1998
Endotoxin tolerance alters macrophage membrane regulatory G proteins.
Progress in clinical and biological research·1998
Molecular mechanisms responsible for endotoxin tolerance.
Progress in clinical and biological research·1998
Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
Progress in clinical and biological research·1998
Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Nivolumab dose stewardship in routine Oncology practice: a real-world health-economic simulation.
Expert review of pharmacoeconomics & outcomes research·2026
Impact of the Multimodal Protocol on the Outcomes of Cancer Patients Undergoing Radical Cystectomy.
Revista do Colegio Brasileiro de Cirurgioes·2026
An Optimized Cancer Cachexia Research Model.
Current protocols·2026
Vitamin C for the prevention of complex regional pain syndrome after foot and ankle fractures or surgery: a systematic review.
European review for medical and pharmacological sciences·2026
Macrophages Are Not Welcome: Potential of CCR1/CCR2 Inhibition for Cytokine Release Prevention.
Cancer immunology research·2026